TP53 and malignant colon neoplasm: SUMO1 and TP53 were found to be interrelated in colon cancer patients; Zhang et al. [87] have found SUMO1 to be significantly over-expressed in colon cancer patients, and that this over-expression leads to accumulation of P53 which in turn promotes colon tumor formation.